Effects of the combination of low-level laser irradiation and recombinant human bone morphogenetic protein-2 in bone repair
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
06/11/2013
06/11/2013
2012
|
Resumo |
Low-level laser irradiation (LLLI) and recombinant human bone morphogenetic protein type 2 (rhBMP-2) have been used to stimulate bone formation. LLLI stimulates proliferation of osteoblast precursor cells and cell differentiation and rhBMP-2 recruits osteoprogenitor cells to the bone healing area. This in vivo study evaluated the effects of LLLI and rhBMP-2 on the bone healing process in rats. Critical bone defects were created in the parietal bone in 42 animals, and the animals were divided into six treatment groups: (1) laser, (2) 7 mu g of rhBMP-2, (3) laser and 7 mu g of rhBMP-2, (4) 7 mu g of rhBMP-2/monoolein gel, (5) laser and 7 mu g rhBMP-2/monoolein gel, and (6) critical bone defect controls. A gallium-aluminum-arsenide diode laser was used (wavelength 780 nm, output power 60 mW, beam area 0.04 cm(2), irradiation time 80 s, energy density 120 J/cm(2), irradiance 1.5 W/cm(2)). After 15 days, the calvarial tissues were removed for histomorphometric analysis. Group 3 defects showed higher amounts of newly formed bone (37.89%) than the defects of all the other groups (P < 0.05). The amounts of new bone in defects of groups 1 and 4 were not significantly different from each other (24.00% and 24.75%, respectively), but were significantly different from the amounts in the other groups (P < 0.05). The amounts of new bone in the defects of groups 2 and 5 were not significantly different from each other (31.42% and 31.96%, respectively), but were significantly different from the amounts in the other groups (P < 0.05). Group 6 defects had 14.10% new bone formation, and this was significantly different from the amounts in the other groups (P < 0.05). It can be concluded that LLLI administered during surgery effectively accelerated healing of critical bone defects filled with pure rhBMP-2, achieving a better result than LLLI alone or the use of rhBMP-2 alone. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/51480-4] Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Pro-Reitoria de Pesquisa da Universidade de Sao Paulo |
Identificador |
LASERS IN MEDICAL SCIENCE, LONDON, v. 27, n. 5, pp. 971-977, SEP, 2012 0268-8921 http://www.producao.usp.br/handle/BDPI/42626 10.1007/s10103-011-1022-y |
Idioma(s) |
eng |
Publicador |
SPRINGER LONDON LTD LONDON |
Relação |
LASERS IN MEDICAL SCIENCE |
Direitos |
closedAccess Copyright SPRINGER LONDON LTD |
Palavras-Chave | #LOW-LEVEL LASER IRRADIATION #BONE REPAIR #BONE MORPHOGENETIC PROTEINS #ANIMALS #IN-VITRO #DEFECTS #THERAPY #RHBMP-2 #LIGHT #CELLS #RATS #ENGINEERING, BIOMEDICAL #SURGERY |
Tipo |
article original article publishedVersion |